1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,395 | 2,680 | 09:57 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.10. | ATRYS HEALTH, S.A.: Atrys announces the appointment of Anabel López as Non-Executive Chair | 1 | CNMV | ||
| ATRYS HEALTH Aktie jetzt für 0€ handeln | |||||
| 10.09. | ATRYS HEALTH, S.A.: Atrys issues a press release regarding the presentation of its first-semester 2026 results | 1 | CNMV | ||
| 10.09. | ATRYS HEALTH, S.A.: Atrys issues a press release regarding the presentation of its first-quarter 2026 results | 1 | CNMV | ||
| 31.07. | ATRYS HEALTH, S.A.: Atrys announces the presentation of the first half financial results for 2026. | 1 | CNMV | ||
| 18.06. | ATRYS HEALTH, S.A.: Atrys provides the presentation for the Ordinary General Shareholders' Meeting, which is expected to be held on first call today, June 18, 2026 | 2 | CNMV | ||
| 21.05. | ATRYS HEALTH, S.A.: Atrys submits the presentation of results for Q1 2026 | 1 | CNMV | ||
| 21.05. | ATRYS HEALTH, S.A.: Atrys Health submits the press release regarding its Q1 2026 results | 1 | CNMV | ||
| 21.05. | ATRYS HEALTH, S.A.: Atrys Health submits the Q1 2026 results presentation | 3 | CNMV | ||
| 13.05. | ATRYS HEALTH, S.A.: Atrys announces the presentation of its results for the first quarter of 2026 | 1 | CNMV |
9 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ADAPTHEALTH | 6,065 | 0,00 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,65 | 0,00 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| ALIGNMENT HEALTHCARE | 8,720 | +0,11 % | Alignment Healthcare earns 4-Star or higher ratings for six plans | ||
| HEARTFLOW | 47,590 | -0,08 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| BILLIONTOONE | 95,41 | 0,00 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| PROGYNY | 27,820 | -0,04 % | Progyny expects 1.2 million new covered lives in 2027 | ||
| AVEANNA HEALTHCARE | 12,235 | -0,04 % | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | ||
| PRIVIA HEALTH GROUP | 20,180 | -0,05 % | Privia Health Group, Inc.: Privia Health to Report Third Quarter 2026 Results on Thursday, November 5 | ||
| GENEDX | 67,67 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| LIFESTANCE HEALTH GROUP | 12,060 | 0,00 % | Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call | ||
| FRESENIUS | 42,480 | +2,14 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius vor einem Treffen mit dem Chef Michael Sen auf "Buy" mit einem Kursziel von 55 Euro belassen. Die geschäftliche... ► Artikel lesen | |
| BETA BIONICS | 17,440 | +0,06 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,620 | +2,45 % | Fresenius Medical Care: Plötzlicher Führungswechsel schürt Zweifel an Zukunft - Kurs bricht weiter ein | Der überraschende Führungswechsel bei Fresenius Medical Care lässt die Aktie abstürzen und schürt Spekulationen über einen radikalen Kurswechsel im angeschlagenen Dialysegeschäft. Anleger und Analysten... ► Artikel lesen | |
| CONCENTRA GROUP | 36,670 | 0,00 % | Why Concentra's Quiet Healthcare Business Keeps Winning | ||
| NEUROPACE | 12,390 | 0,00 % | KeyBanc initiates NeuroPace stock coverage with overweight rating |
ATRYS HEALTH SA gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 2,230 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ATRYS HEALTH SA finden Sie auf Wallstreet Online.